Global and Japan Glaucoma Medications Market Insights, Forecast to 2027
SKU ID : QYR-18762241 | Publishing Date : 19-Jul-2021 | No. of pages : 154
Detailed TOC of Global and Japan Glaucoma Medications Market Insights, Forecast to 2027
1 Study Coverage1.1 Glaucoma Medications Product Introduction
1.2 Market by Type
1.2.1 Global Glaucoma Medications Market Size Growth Rate by Type
1.2.2 Prostaglandin Analogs
1.2.3 Beta Blockers
1.2.4 Alpha Agonists
1.2.5 Carbonic Anhydrase Inhibitors
1.2.6 Combined Medications
1.3 Market by Application
1.3.1 Global Glaucoma Medications Market Size Growth Rate by Application
1.3.2 Open-angle Glaucoma
1.3.3 Closed-angle Glaucoma
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Glaucoma Medications Market Size, Estimates and Forecasts
2.1.1 Global Glaucoma Medications Revenue 2016-2027
2.1.2 Global Glaucoma Medications Sales 2016-2027
2.2 Global Glaucoma Medications, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Glaucoma Medications Historical Market Size by Region (2016-2021)
2.3.1 Global Glaucoma Medications Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Glaucoma Medications Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Glaucoma Medications Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Glaucoma Medications Sales Forecast by Region (2022-2027)
2.4.2 Global Glaucoma Medications Revenue Forecast by Region (2022-2027)
3 Global Glaucoma Medications Competitor Landscape by Players
3.1 Global Top Glaucoma Medications Manufacturers by Sales
3.1.1 Global Glaucoma Medications Sales by Manufacturer (2016-2021)
3.1.2 Global Glaucoma Medications Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Glaucoma Medications Manufacturers by Revenue
3.2.1 Key Glaucoma Medications Manufacturers Covered: Ranking by Revenue
3.2.2 Global Glaucoma Medications Revenue by Manufacturers (2016-2021)
3.2.3 Global Glaucoma Medications Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Glaucoma Medications Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Glaucoma Medications Revenue in 2020
3.2.6 Global Glaucoma Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Glaucoma Medications Price by Manufacturers
3.4 Global Glaucoma Medications Manufacturing Base Distribution, Product Types
3.4.1 Glaucoma Medications Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glaucoma Medications Product Type
3.4.3 Date of International Manufacturers Enter into Glaucoma Medications Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Glaucoma Medications Market Size by Type (2016-2021)
4.1.1 Global Glaucoma Medications Sales by Type (2016-2021)
4.1.2 Global Glaucoma Medications Revenue by Type (2016-2021)
4.1.3 Glaucoma Medications Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Glaucoma Medications Market Size Forecast by Type (2022-2027)
4.2.1 Global Glaucoma Medications Sales Forecast by Type (2022-2027)
4.2.2 Global Glaucoma Medications Revenue Forecast by Type (2022-2027)
4.2.3 Glaucoma Medications Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Glaucoma Medications Market Size by Application (2016-2021)
5.1.1 Global Glaucoma Medications Sales by Application (2016-2021)
5.1.2 Global Glaucoma Medications Revenue by Application (2016-2021)
5.1.3 Glaucoma Medications Price by Application (2016-2021)
5.2 Glaucoma Medications Market Size Forecast by Application (2022-2027)
5.2.1 Global Glaucoma Medications Sales Forecast by Application (2022-2027)
5.2.2 Global Glaucoma Medications Revenue Forecast by Application (2022-2027)
5.2.3 Global Glaucoma Medications Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Glaucoma Medications Market Size YoY Growth 2016-2027
6.1.1 Japan Glaucoma Medications Sales YoY Growth 2016-2027
6.1.2 Japan Glaucoma Medications Revenue YoY Growth 2016-2027
6.1.3 Japan Glaucoma Medications Market Share in Global Market 2016-2027
6.2 Japan Glaucoma Medications Market Size by Players (International and Local Players)
6.2.1 Japan Top Glaucoma Medications Players by Sales (2016-2021)
6.2.2 Japan Top Glaucoma Medications Players by Revenue (2016-2021)
6.3 Japan Glaucoma Medications Historic Market Review by Type (2016-2021)
6.3.1 Japan Glaucoma Medications Sales Market Share by Type (2016-2021)
6.3.2 Japan Glaucoma Medications Revenue Market Share by Type (2016-2021)
6.3.3 Japan Glaucoma Medications Price by Type (2016-2021)
6.4 Japan Glaucoma Medications Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Glaucoma Medications Sales Forecast by Type (2022-2027)
6.4.2 Japan Glaucoma Medications Revenue Forecast by Type (2022-2027)
6.4.3 Japan Glaucoma Medications Price Forecast by Type (2022-2027)
6.5 Japan Glaucoma Medications Historic Market Review by Application (2016-2021)
6.5.1 Japan Glaucoma Medications Sales Market Share by Application (2016-2021)
6.5.2 Japan Glaucoma Medications Revenue Market Share by Application (2016-2021)
6.5.3 Japan Glaucoma Medications Price by Application (2016-2021)
6.6 Japan Glaucoma Medications Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Glaucoma Medications Sales Forecast by Application (2022-2027)
6.6.2 Japan Glaucoma Medications Revenue Forecast by Application (2022-2027)
6.6.3 Japan Glaucoma Medications Price Forecast by Application (2022-2027)
7 North America
7.1 North America Glaucoma Medications Market Size YoY Growth 2016-2027
7.2 North America Glaucoma Medications Market Facts & Figures by Country
7.2.1 North America Glaucoma Medications Sales by Country (2016-2021)
7.2.2 North America Glaucoma Medications Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Glaucoma Medications Market Size YoY Growth 2016-2027
8.2 Asia Pacific Glaucoma Medications Market Facts & Figures by Region
8.2.1 Asia Pacific Glaucoma Medications Sales by Region (2016-2021)
8.2.2 Asia Pacific Glaucoma Medications Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Glaucoma Medications Market Size YoY Growth 2016-2027
9.2 Europe Glaucoma Medications Market Facts & Figures by Country
9.2.1 Europe Glaucoma Medications Sales by Country (2016-2021)
9.2.2 Europe Glaucoma Medications Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Glaucoma Medications Market Size YoY Growth 2016-2027
10.2 Latin America Glaucoma Medications Market Facts & Figures by Country
10.2.1 Latin America Glaucoma Medications Sales by Country (2016-2021)
10.2.2 Latin America Glaucoma Medications Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Glaucoma Medications Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Glaucoma Medications Market Facts & Figures by Country
11.2.1 Middle East and Africa Glaucoma Medications Sales by Country (2016-2021)
11.2.2 Middle East and Africa Glaucoma Medications Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Glaucoma Medications Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Glaucoma Medications Products Offered
12.2.5 Novartis Recent Development
12.3 bausch Lomb
12.3.1 bausch Lomb Corporation Information
12.3.2 bausch Lomb Description and Business Overview
12.3.3 bausch Lomb Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.3.4 bausch Lomb Glaucoma Medications Products Offered
12.3.5 bausch Lomb Recent Development
12.4 Laboratoire Riva
12.4.1 Laboratoire Riva Corporation Information
12.4.2 Laboratoire Riva Description and Business Overview
12.4.3 Laboratoire Riva Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Laboratoire Riva Glaucoma Medications Products Offered
12.4.5 Laboratoire Riva Recent Development
12.5 Jamp Pharma
12.5.1 Jamp Pharma Corporation Information
12.5.2 Jamp Pharma Description and Business Overview
12.5.3 Jamp Pharma Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Jamp Pharma Glaucoma Medications Products Offered
12.5.5 Jamp Pharma Recent Development
12.6 Fresenius
12.6.1 Fresenius Corporation Information
12.6.2 Fresenius Description and Business Overview
12.6.3 Fresenius Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fresenius Glaucoma Medications Products Offered
12.6.5 Fresenius Recent Development
12.7 Teva Pharmaceutical?
12.7.1 Teva Pharmaceutical? Corporation Information
12.7.2 Teva Pharmaceutical? Description and Business Overview
12.7.3 Teva Pharmaceutical? Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Pharmaceutical? Glaucoma Medications Products Offered
12.7.5 Teva Pharmaceutical? Recent Development
12.8 SANDOZ
12.8.1 SANDOZ Corporation Information
12.8.2 SANDOZ Description and Business Overview
12.8.3 SANDOZ Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.8.4 SANDOZ Glaucoma Medications Products Offered
12.8.5 SANDOZ Recent Development
12.9 Greenstone
12.9.1 Greenstone Corporation Information
12.9.2 Greenstone Description and Business Overview
12.9.3 Greenstone Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Greenstone Glaucoma Medications Products Offered
12.9.5 Greenstone Recent Development
12.10 Mylan
12.10.1 Mylan Corporation Information
12.10.2 Mylan Description and Business Overview
12.10.3 Mylan Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Mylan Glaucoma Medications Products Offered
12.10.5 Mylan Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Glaucoma Medications Products Offered
12.11.5 Pfizer Recent Development
12.12 Mint Pharmaceuticals
12.12.1 Mint Pharmaceuticals Corporation Information
12.12.2 Mint Pharmaceuticals Description and Business Overview
12.12.3 Mint Pharmaceuticals Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Mint Pharmaceuticals Products Offered
12.12.5 Mint Pharmaceuticals Recent Development
12.13 Laboratoires Thea
12.13.1 Laboratoires Thea Corporation Information
12.13.2 Laboratoires Thea Description and Business Overview
12.13.3 Laboratoires Thea Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Laboratoires Thea Products Offered
12.13.5 Laboratoires Thea Recent Development
12.14 Taj Pharmaceuticals
12.14.1 Taj Pharmaceuticals Corporation Information
12.14.2 Taj Pharmaceuticals Description and Business Overview
12.14.3 Taj Pharmaceuticals Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Taj Pharmaceuticals Products Offered
12.14.5 Taj Pharmaceuticals Recent Development
12.15 Actavis
12.15.1 Actavis Corporation Information
12.15.2 Actavis Description and Business Overview
12.15.3 Actavis Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Actavis Products Offered
12.15.5 Actavis Recent Development
12.16 APOTEX
12.16.1 APOTEX Corporation Information
12.16.2 APOTEX Description and Business Overview
12.16.3 APOTEX Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.16.4 APOTEX Products Offered
12.16.5 APOTEX Recent Development
12.17 Sun Pharma
12.17.1 Sun Pharma Corporation Information
12.17.2 Sun Pharma Description and Business Overview
12.17.3 Sun Pharma Glaucoma Medications Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Sun Pharma Products Offered
12.17.5 Sun Pharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Glaucoma Medications Industry Trends
13.2 Glaucoma Medications Market Drivers
13.3 Glaucoma Medications Market Challenges
13.4 Glaucoma Medications Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glaucoma Medications Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and Japan Glaucoma Medications Market Insights, Forecast to 2027
List of TablesTable 1. Global Glaucoma Medications Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Prostaglandin Analogs
Table 3. Major Manufacturers of Beta Blockers
Table 4. Major Manufacturers of Alpha Agonists
Table 5. Major Manufacturers of Carbonic Anhydrase Inhibitors
Table 6. Major Manufacturers of Combined Medications
Table 7. Global Glaucoma Medications Market Size Growth Rate by Application (2021-2027) & (MT)
Table 8. Global Glaucoma Medications Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Glaucoma Medications Sales by Regions (2016-2021) & (MT)
Table 10. Global Glaucoma Medications Sales Market Share by Regions (2016-2021)
Table 11. Global Glaucoma Medications Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Glaucoma Medications Sales Forecast by Region (2022-2027) & (MT)
Table 13. Global Glaucoma Medications Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Glaucoma Medications Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Glaucoma Medications Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Glaucoma Medications Sales by Manufacturers (2016-2021) (MT)
Table 17. Global Glaucoma Medications Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Glaucoma Medications Manufacturers by Revenue (US$ Million) in 2020
Table 19. Glaucoma Medications Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Glaucoma Medications Revenue Share by Manufacturers (2016-2021)
Table 21. Global Glaucoma Medications Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Glaucoma Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glaucoma Medications as of 2020)
Table 23. Key Manufacturers Glaucoma Medications Price (2016-2021) (USD/Kg)
Table 24. Glaucoma Medications Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Glaucoma Medications Product Type
Table 26. Date of International Manufacturers Enter into Glaucoma Medications Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Glaucoma Medications Sales by Type (2016-2021) (MT)
Table 29. Global Glaucoma Medications Sales Share by Type (2016-2021)
Table 30. Global Glaucoma Medications Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Glaucoma Medications Revenue Share by Type (2016-2021)
Table 32. Glaucoma Medications Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 33. Global Glaucoma Medications Sales Forecast by Type (2022-2027) & (MT)
Table 34. Global Glaucoma Medications Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Glaucoma Medications Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Glaucoma Medications Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Glaucoma Medications Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 38. Global Glaucoma Medications Sales by Application (2016-2021) (MT)
Table 39. Global Glaucoma Medications Sales Share by Application (2016-2021)
Table 40. Global Glaucoma Medications Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Glaucoma Medications Revenue Share by Application (2016-2021)
Table 42. Glaucoma Medications Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 43. Global Glaucoma Medications Sales Forecast by Application (2022-2027) & (MT)
Table 44. Global Glaucoma Medications Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Glaucoma Medications Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Glaucoma Medications Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Glaucoma Medications Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 48. Japan Glaucoma Medications Sales (MT) of Key Companies (2016-2021)
Table 49. Japan Glaucoma Medications Sales Share by Company (2016-2021)
Table 50. Japan Glaucoma Medications Revenue (US$ Million) by Company (2016-2021)
Table 51. Japan Glaucoma Medications Revenue Share by Company (2016-2021)
Table 52. Japan Glaucoma Medications Sales (MT) by Type (2016-2021)
Table 53. Japan Glaucoma Medications Sales Share by Type (2016-2021)
Table 54. Japan Glaucoma Medications Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. Japan Glaucoma Medications Price (USD/Kg) by Type (2016-2021)
Table 56. Japan Glaucoma Medications Sales (MT) by Type (2022-2027)
Table 57. Japan Glaucoma Medications Sales Share by Type (2022-2027)
Table 58. Japan Glaucoma Medications Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. Japan Glaucoma Medications Revenue Share by Type (2022-2027)
Table 60. Japan Glaucoma Medications Price (USD/Kg) by Type (2022-2027)
Table 61. Japan Glaucoma Medications Sales (MT) by Application (2016-2021)
Table 62. Japan Glaucoma Medications Sales Share by Application (2016-2021)
Table 63. Japan Glaucoma Medications Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. Japan Glaucoma Medications Price (USD/Kg) by Application (2016-2021)
Table 65. Japan Glaucoma Medications Sales (MT) by Application (2022-2027)
Table 66. Japan Glaucoma Medications Sales Share by Application (2022-2027)
Table 67. Japan Glaucoma Medications Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. Japan Glaucoma Medications Revenue Share by Application (2022-2027)
Table 69. Japan Glaucoma Medications Price (USD/Kg) by Application (2022-2027)
Table 70. North America Glaucoma Medications Sales by Country (2016-2021) & (MT)
Table 71. North America Glaucoma Medications Sales Market Share by Country (2016-2021)
Table 72. North America Glaucoma Medications Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Glaucoma Medications Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Glaucoma Medications Sales by Region (2016-2021) & (MT)
Table 75. Asia Pacific Glaucoma Medications Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Glaucoma Medications Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Glaucoma Medications Revenue Market Share by Region (2016-2021)
Table 78. Europe Glaucoma Medications Sales by Country (2016-2021) & (MT)
Table 79. Europe Glaucoma Medications Sales Market Share by Country (2016-2021)
Table 80. Europe Glaucoma Medications Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Glaucoma Medications Revenue Market Share by Country (2016-2021)
Table 82. Latin America Glaucoma Medications Sales by Country (2016-2021) & (MT)
Table 83. Latin America Glaucoma Medications Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Glaucoma Medications Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Glaucoma Medications Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Glaucoma Medications Sales by Country (2016-2021) & (MT)
Table 87. Middle East and Africa Glaucoma Medications Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Glaucoma Medications Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Glaucoma Medications Revenue Market Share by Country (2016-2021)
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 93. Pfizer Glaucoma Medications Product
Table 94. Pfizer Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 98. Novartis Product
Table 99. Novartis Recent Development
Table 100. bausch Lomb Corporation Information
Table 101. bausch Lomb Description and Business Overview
Table 102. bausch Lomb Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 103. bausch Lomb Product
Table 104. bausch Lomb Recent Development
Table 105. Laboratoire Riva Corporation Information
Table 106. Laboratoire Riva Description and Business Overview
Table 107. Laboratoire Riva Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 108. Laboratoire Riva Product
Table 109. Laboratoire Riva Recent Development
Table 110. Jamp Pharma Corporation Information
Table 111. Jamp Pharma Description and Business Overview
Table 112. Jamp Pharma Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Jamp Pharma Product
Table 114. Jamp Pharma Recent Development
Table 115. Fresenius Corporation Information
Table 116. Fresenius Description and Business Overview
Table 117. Fresenius Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Fresenius Product
Table 119. Fresenius Recent Development
Table 120. Teva Pharmaceutical? Corporation Information
Table 121. Teva Pharmaceutical? Description and Business Overview
Table 122. Teva Pharmaceutical? Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Teva Pharmaceutical? Product
Table 124. Teva Pharmaceutical? Recent Development
Table 125. SANDOZ Corporation Information
Table 126. SANDOZ Description and Business Overview
Table 127. SANDOZ Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. SANDOZ Product
Table 129. SANDOZ Recent Development
Table 130. Greenstone Corporation Information
Table 131. Greenstone Description and Business Overview
Table 132. Greenstone Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Greenstone Product
Table 134. Greenstone Recent Development
Table 135. Mylan Corporation Information
Table 136. Mylan Description and Business Overview
Table 137. Mylan Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Mylan Product
Table 139. Mylan Recent Development
Table 140. GE Medical Corporation Information
Table 141. GE Medical Description and Business Overview
Table 142. GE Medical Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. GE Medical Product
Table 144. GE Medical Recent Development
Table 145. Mint Pharmaceuticals Corporation Information
Table 146. Mint Pharmaceuticals Description and Business Overview
Table 147. Mint Pharmaceuticals Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 148. Mint Pharmaceuticals Product
Table 149. Mint Pharmaceuticals Recent Development
Table 150. Laboratoires Thea Corporation Information
Table 151. Laboratoires Thea Description and Business Overview
Table 152. Laboratoires Thea Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 153. Laboratoires Thea Product
Table 154. Laboratoires Thea Recent Development
Table 155. Taj Pharmaceuticals Corporation Information
Table 156. Taj Pharmaceuticals Description and Business Overview
Table 157. Taj Pharmaceuticals Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Taj Pharmaceuticals Product
Table 159. Taj Pharmaceuticals Recent Development
Table 160. Actavis Corporation Information
Table 161. Actavis Description and Business Overview
Table 162. Actavis Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. Actavis Product
Table 164. Actavis Recent Development
Table 165. APOTEX Corporation Information
Table 166. APOTEX Description and Business Overview
Table 167. APOTEX Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. APOTEX Product
Table 169. APOTEX Recent Development
Table 170. Sun Pharma Corporation Information
Table 171. Sun Pharma Description and Business Overview
Table 172. Sun Pharma Glaucoma Medications Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 173. Sun Pharma Product
Table 174. Sun Pharma Recent Development
Table 175. Glaucoma Medications Market Trends
Table 176. Glaucoma Medications Market Drivers
Table 177. Glaucoma Medications Market Challenges
Table 178. Glaucoma Medications Market Restraints
Table 179. Glaucoma Medications Customers List
Table 180. Glaucoma Medications Distributors List
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Glaucoma Medications Product Picture
Figure 2. Global Glaucoma Medications Sales Market Share by Type in 2020 & 2027
Figure 3. Prostaglandin Analogs Product Picture
Figure 4. Beta Blockers Product Picture
Figure 5. Alpha Agonists Product Picture
Figure 6. Carbonic Anhydrase Inhibitors Product Picture
Figure 7. Combined Medications Product Picture
Figure 8. Global Glaucoma Medications Sales Market Share by Application in 2020 & 2027
Figure 9. Open-angle Glaucoma
Figure 10. Closed-angle Glaucoma
Figure 11. Glaucoma Medications Report Years Considered
Figure 12. Global Glaucoma Medications Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Glaucoma Medications Market Size 2016-2027 (US$ Million)
Figure 14. Global Glaucoma Medications Sales 2016-2027 (MT)
Figure 15. Global Glaucoma Medications Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Glaucoma Medications Sales Market Share by Region (2016-2021)
Figure 17. Global Glaucoma Medications Sales Market Share by Region in 2020
Figure 18. Global Glaucoma Medications Revenue Market Share by Region (2016-2021)
Figure 19. Global Glaucoma Medications Revenue Market Share by Region in 2020
Figure 20. Global Glaucoma Medications Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Glaucoma Medications Revenue in 2020
Figure 22. Glaucoma Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Glaucoma Medications Sales Market Share by Type (2016-2021)
Figure 24. Global Glaucoma Medications Sales Market Share by Type in 2020
Figure 25. Global Glaucoma Medications Revenue Market Share by Type (2016-2021)
Figure 26. Global Glaucoma Medications Revenue Market Share by Type in 2020
Figure 27. Global Glaucoma Medications Sales Market Share by Application (2016-2021)
Figure 28. Global Glaucoma Medications Sales Market Share by Application in 2020
Figure 29. Global Glaucoma Medications Revenue Market Share by Application (2016-2021)
Figure 30. Global Glaucoma Medications Revenue Market Share by Application in 2020
Figure 31. Japan Glaucoma Medications Sales Growth Rate 2016-2027 (MT)
Figure 32. Japan Glaucoma Medications Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Japan Glaucoma Medications Market Share in Global Market 2016-2027
Figure 34. Japan 5 and 10 Largest Glaucoma Medications Players Market Share by Revenue in Glaucoma Medications in 2020
Figure 35. Japan Glaucoma Medications Revenue Share by Type (2016-2021)
Figure 36. Japan Glaucoma Medications Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Japan Glaucoma Medications Revenue Share by Application (2016-2021)
Figure 38. Japan Glaucoma Medications Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Glaucoma Medications Sales Growth Rate 2016-2021 (MT)
Figure 40. North America Glaucoma Medications Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Glaucoma Medications Sales Market Share by Country in 2020
Figure 42. North America Glaucoma Medications Revenue Market Share by Country in 2020
Figure 43. U.S. Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 44. U.S. Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 46. Canada Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Glaucoma Medications Sales Growth Rate 2016-2021 (MT)
Figure 48. Europe Glaucoma Medications Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Glaucoma Medications Sales Market Share by Country in 2020
Figure 50. Europe Glaucoma Medications Revenue Market Share by Country in 2020
Figure 51. Germany Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 52. Germany Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 54. France Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 56. U.K. Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 58. Italy Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 60. Russia Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Glaucoma Medications Sales Growth Rate 2016-2021 (MT)
Figure 62. Asia Pacific Glaucoma Medications Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Glaucoma Medications Sales Market Share by Region in 2020
Figure 64. Asia Pacific Glaucoma Medications Revenue Market Share by Region in 2020
Figure 65. China Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 66. China Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 68. Japan Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 70. South Korea Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 72. India Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 74. Australia Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 76. Taiwan Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 78. Indonesia Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 80. Thailand Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 82. Malaysia Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 84. Philippines Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 86. Vietnam Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Glaucoma Medications Sales Growth Rate 2016-2021 (MT)
Figure 88. Latin America Glaucoma Medications Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Glaucoma Medications Sales Market Share by Country in 2020
Figure 90. Latin America Glaucoma Medications Revenue Market Share by Country in 2020
Figure 91. Mexico Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 92. Mexico Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 94. Brazil Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 96. Argentina Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Glaucoma Medications Sales Growth Rate 2016-2021 (MT)
Figure 98. Middle East and Africa Glaucoma Medications Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Glaucoma Medications Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Glaucoma Medications Revenue Market Share by Country in 2020
Figure 101. Turkey Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 102. Turkey Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 104. Saudi Arabia Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. U.A.E Glaucoma Medications Sales Growth Rate (2016-2021) (MT)
Figure 106. U.A.E Glaucoma Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Glaucoma Medications Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
Keyplayers in Global and Japan Glaucoma Medications Market Insights, Forecast to 2027
PfizerNovartis
bausch Lomb
Laboratoire Riva
Jamp Pharma
Fresenius
Teva Pharmaceutical?
SANDOZ
Greenstone
Mylan
GE Medical
Mint Pharmaceuticals
Laboratoires Thea
Taj Pharmaceuticals
Actavis
APOTEX
Sun Pharma